Back to top
more

Masimo (MASI)

(Delayed Data from NSDQ)

$124.50 USD

124.50
1,191,499

-1.67 (-1.32%)

Updated May 31, 2024 04:00 PM ET

After-Market: $124.48 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (147 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for MASI

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Masimo Corporation [MASI]

Reports for Purchase

Showing records 341 - 360 ( 482 total )

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 341

04/30/2014

Company Report

Pages: 4

1Q Preview: Modest 1Q Expectations Achievable

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 342

04/14/2014

Daily Note

Pages: 24

1Q Preview: Expecting a Seasonally Soft Quarter but Fundamentals Remain Intact

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 343

04/14/2014

Daily Note

Pages: 24

1Q Preview: Expecting a Seasonally Soft Quarter but Fundamentals Remain Intact

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 344

04/07/2014

Industry Report

Pages: 8

Healthcare: 1Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation Update

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 345

02/18/2014

Company Report

Pages: 8

Price: 24.95

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 346

02/14/2014

Company Report

Pages: 6

4Q Review: Many Moving Parts to ''14 Outlook; Maintain OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 347

02/14/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 348

02/14/2014

Company Report

Pages: 9

Q4 results largely inline, ex-items, 2014 guidance mixed vs. prior consensus

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 349

02/14/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 350

02/14/2014

Company Report

Pages: 9

Royalty Uncertainty Leads to Wider Guidance but Underlying Outlook Inline

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 351

02/13/2014

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 352

02/13/2014

Company Report

Pages: 4

4Q13 Preview: Tracking To Solid 4Q; Street?s FY14 EPS May be Aggressive

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 353

02/11/2014

Company Report

Pages: 6

4Q13 Preview - Focus on 2014 Guidance and Any Royalty Update

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 354

01/08/2014

Industry Report

Pages: 4

Preannouncement Watch - Look for Med Tech News into Next Week?s HC Conference

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 355

11/14/2013

Company Report

Pages: 5

Management Meetings Support Our Positive Thesis: We See Gold At the End of the Rainbow

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 356

10/31/2013

Company Report

Pages: 8

Q3 results mixed, 2013 EPS guidance increased by $0.02, maintain HOLD

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 357

10/31/2013

Company Report

Pages: 6

Solid 3Q13 Results Set the Stage for Robust 2014 Product Sales; Increasing PT to $31

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 358

10/31/2013

Company Report

Pages: 7

3Q Mixed but ?13 EPS Guidance Raised; Raising PT to $32; Buy

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 359

10/31/2013

Company Report

Pages: 8

Price: 24.95

Company: Masimo Corporation

Industry: Medical - Instruments

Record: 360

10/30/2013

Daily Note

Pages: 5

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party